Asset AcquisitionThe anticipated acquisition of the helium-rich Renergen asset continues to assemble an impressive portfolio of assets.
Strategic OpportunitiesASP stands at the threshold of a major opportunity, targeting the supply of critical, hard-to-source isotopes essential to the medical, semiconductor, and nuclear sectors.
Technological InnovationThe QLE laser enrichment technology has the potential to reshape the industry.